Jill Ker Conway

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Randomized phase 2 trial of NP001, a novel immune regulator

Robert G. Miller, Gilbert Block, Jonathan Katz et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 94 citations · Full text

When Memory Speaks: Reflections on Autobiography.

Joyce Antler, Jill Ker Conway · Journal of American History · 1999 · 77 citations

Intellectual History, Literary History, Early American Literature +11

Perspectives on the History of Women's Education in the United States

Jill Ker Conway · History of Education Quarterly · 1974 · 38 citations

Women Empowerment, Education, Queer Theory +27